Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

NCT01491113 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Renal Impairments

Interventions

DRUG: Levetiracetam 250 mg
DRUG: Levetiracetam 500 mg

Sponsor

UCB Pharma

Collaborators

[object Object]